Skip to main content
OpenTrials
Completed

NCT Number: NCT04533035

Lower Limb Tissue Oxygenation Using Near-infrared Spectroscopy During Hallux Valgus Operation

In acute lower limb ischemia the main goal of the treatment is to restore the blood before irreversible damage to the soft tissues of the limb. Delays in identifying acute lower limb ischemia may lead to limb loss or lead to the loss of the patient. Situations in which the patient is unable to express symptoms of the acute lower limb ischemia, such as during general anesthesia, in intensive care, or immediately after vascular surgery, are challenging for medical staff to identify. A reliable, easy-to-use and non-invasive monitoring method is not yet in every day use. The aim of this study is to demonstrate that Near InfraRed Spectroscopy (NIRS) monitoring is such a monitoring method.

Tourniquet induced ischemia is often used in hallux valgus surgery because it offers a bloodless view of the anatomical structures. In our study we will measure the soft tissue perfusion (rSO2) of the lower limbs during the whole operation. The sensors based on near-infrared spectroscopy will be located to the tibial surface and will record the normal state before the start of the tourniquet, during the tourniquet and also in the recovery phase.

The hypothesis is that rSO2 decreases linearly as a function of time from the beginning of the tourniquet induced ischemia and the recovery time depends on the duration of the tourniquet. In our study the patients will be operated under a spinal anesthesia. We also hypothesise that rSO2 increases due to the induction of the spinal anesthesia. Our goal is to define the percentual decline of rSO2 that is significant for lower limb ischemia and also its time response to induction of ischemia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kuopio University Hospital

Kuopio, 70100, Finland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient understands the meaning of the study and related measures.
  • Patient gives his or her written informed consent.
  • A tourniquet is used.
  • The procedure is performed under spinal anesthesia.
  • Body mass index under 40.

Exclusion criteria

  • Patient belongs to any of the following special groups: disabled people, minor, pregnant or breast feeding women, convicts, forensic psychiatric patients.
  • Previous lower limb vascular surgery.
  • Previous lower limb deep vein thrombosis.
  • Previously performed tibial fasciotomies.
  • Any another reason why the researcher considers that the patient is not suitable for the study.

Treatment and study plan

Primary outcomes

  1. The percentual decrease of the regional oxygen saturation in the lower limb 15 minutes after the tourniquet is applied.

    Time frame: 15 minutes from tourniquet application

    50% decrease from baseline NIRS value in 15 minutes

Secondary outcomes

  1. The time that the regional oxygen saturation in the lower limb takes to recover after the tourniquet is released.

    Time frame: From the moment tourniquet is released to the point that NIRS value reaches it's baseline or patient is mobilised in the recovery room, whichever came first, assessed up to two hours.

    The time to NIRS value to reach baseline value after tourniquet is released

  2. The percentual increase of the regional oxygen saturation in the lower limbs due to the induction of a spinal anesthesia.

    Time frame: 30 minutes from induction of spinal anesthesia

    10% increase in NIRS value after 30 minutes after spinal anesthesia induction

Sponsors and collaborators

Lead sponsor

Kuopio University Hospital

Other

Registry information

Acronym: INVOHV

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Aug 31, 2020
Registry last updated
Mar 2, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.